PHARMING GROUP NV (PHARM.AS) Stock Price, Quote, News and Overview

What is the stock price of PHARMING GROUP NV today?

The current stock price of PHARM.AS is 0.758 EUR. The price decreased by -1.49% in the last trading session.

What is the ticker symbol for PHARMING GROUP NV stock?

The exchange symbol of PHARMING GROUP NV is PHARM and it is listed on the Euronext Amsterdam exchange.

On which exchange is PHARM.AS stock listed?

PHARM.AS stock is listed on the Euronext Amsterdam exchange.

What is the price forecast or stock price prediction for PHARMING GROUP NV stock?

12 analysts have analysed PHARM.AS and the average price target is 7.15 EUR. This implies a price increase of 843.53% is expected in the next year compared to the current price of 0.758. Check the PHARMING GROUP NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is PHARMING GROUP NV worth?

PHARMING GROUP NV (PHARM.AS) has a market capitalization of 51.42M EUR. This makes PHARM.AS a Micro Cap stock.

How many employees does PHARMING GROUP NV have?

PHARMING GROUP NV (PHARM.AS) currently has 382 employees.

What are the support and resistance levels for PHARMING GROUP NV (PHARM.AS) stock?

PHARMING GROUP NV (PHARM.AS) has a support level at 0.75 and a resistance level at 0.81. Check the full technical report for a detailed analysis of PHARM.AS support and resistance levels.

Is PHARMING GROUP NV (PHARM.AS) expected to grow?

The Revenue of PHARMING GROUP NV (PHARM.AS) is expected to grow by 18.78% in the next year. Check the estimates tab for more information on the PHARM.AS EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy PHARMING GROUP NV (PHARM.AS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of PHARM.AS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of PHARM.AS, evaluating the profitability, health, valuation and growth aspects
• PHARMING GROUP NV (PHARM.AS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• PHARMING GROUP NV (PHARM.AS) Sales and EPS estimates to see what analysts future expectations are.
• PHARMING GROUP NV (PHARM.AS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• PHARMING GROUP NV (PHARM.AS) Insider and Institutional Ownership to learn about the owners and their transactions.
• PHARMING GROUP NV (PHARM.AS) Stock Chart to make your own analysis
• PHARMING GROUP NV (PHARM.AS) Latest news and press-releases to stay up to date.

Does PHARMING GROUP NV (PHARM.AS) stock pay dividends?

PHARM.AS does not pay a dividend.

When does PHARMING GROUP NV (PHARM.AS) report earnings?

PHARMING GROUP NV (PHARM.AS) will report earnings on 2025-03-13, before the market open.

What is the Price/Earnings (PE) ratio of PHARMING GROUP NV (PHARM.AS)?

PHARMING GROUP NV (PHARM.AS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).

ChartMill assigns a fundamental rating of 3 / 10 to PHARM.AS. While PHARM.AS seems to be doing ok healthwise, there are quite some concerns on its profitability.

Over the last trailing twelve months PHARM.AS reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -3.13% compared to the year before.

ChartMill assigns a Buy % Consensus number of 87% to PHARM.AS. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 0.22% and a revenue growth 18.78% for PHARM.AS